<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37269968</PMID><DateCompleted><Year>2023</Year><Month>07</Month><Day>12</Day></DateCompleted><DateRevised><Year>2023</Year><Month>07</Month><Day>18</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1872-8278</ISSN><JournalIssue CitedMedium="Internet"><Volume>71</Volume><PubDate><Year>2023</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Mitochondrion</Title><ISOAbbreviation>Mitochondrion</ISOAbbreviation></Journal><ArticleTitle>Mitochondrial dysfunction and oxidative stress in Alzheimer's disease, and Parkinson's disease, Huntington's disease and Amyotrophic Lateral Sclerosis -An updated review.</ArticleTitle><Pagination><StartPage>83</StartPage><EndPage>92</EndPage><MedlinePgn>83-92</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.mito.2023.05.007</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1567-7249(23)00051-X</ELocationID><Abstract><AbstractText>Misfolded proteins in the central nervous system can induce oxidative damage, which can contribute to neurodegenerative diseases in the mitochondria. Neurodegenerative patients face early mitochondrial dysfunction, impacting energy utilization. Amyloid-&#xdf; and tau problems both have an effect on mitochondria, which leads to mitochondrial malfunction and, ultimately, the onset of Alzheimer's disease. Cellular oxygen interaction yields reactive oxygen species within mitochondria, initiating oxidative damage to mitochondrial constituents. Parkinson's disease, linked to oxidative stress, &#x3b1;-synuclein aggregation, and inflammation, results from reduced brain mitochondria activity. Mitochondrial dynamics profoundly influence cellular apoptosis via distinct causative mechanisms. The condition known as Huntington's disease is characterized by an expansion of polyglutamine, primarily impactingthe cerebral cortex and striatum. Research has identified mitochondrial failure as an early pathogenic mechanism contributing to HD's selective neurodegeneration. The mitochondria are organelles that exhibit dynamism by undergoing fragmentation and fusion processes to attain optimal bioenergetic efficiency. They can also be transported along microtubules and regulateintracellular calcium homeostasis through their interaction with the endoplasmic reticulum. Additionally, the mitochondria produce free radicals. The functions of eukaryotic cells, particularly in neurons, have significantly deviated from the traditionally assigned role of cellular energy production. Most of them areimpaired in HD, which may lead to neuronal dysfunction before symptoms manifest. This article summarizes the most important changes in mitochondrial dynamics that come from neurodegenerative diseases including Alzheimer's, Parkinson's, Huntington's and Amyotrophic Lateral Sclerosis. Finally, we discussed about novel techniques that can potentially treat mitochondrial malfunction and oxidative stress in four most dominating neuro disorders.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Elsevier B.V. and Mitochondria Research Society. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Alqahtani</LastName><ForeName>Taha</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, College of Pharmacy, King Khalid University, Abha 62529, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deore</LastName><ForeName>Sharada L</ForeName><Initials>SL</Initials><AffiliationInfo><Affiliation>Government College of Pharmacy, Amravati, Maharastra 444604, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kide</LastName><ForeName>Anjali A</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Government College of Pharmacy, Amravati, Maharastra 444604, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shende</LastName><ForeName>Bhavana A</ForeName><Initials>BA</Initials><AffiliationInfo><Affiliation>Government College of Pharmacy, Amravati, Maharastra 444604, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sharma</LastName><ForeName>Ritika</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>University Institute of Pharma Sciences, Chandigarh University, Mohali, Punjab 140413, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dadarao Chakole</LastName><ForeName>Rita</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Government College of Pharmacy, Vidyanagar, Karad, Maharashtra 415124, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nemade</LastName><ForeName>Lalita S</ForeName><Initials>LS</Initials><AffiliationInfo><Affiliation>Govindrao Nikam College of Pharmacy, Sawarde, Maharashtra 415606, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kishor Kale</LastName><ForeName>Nikita</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>PES's Modern College of Pharmacy, Nigdi, Pune, Maharashtra 411044, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Borah</LastName><ForeName>Sudarshana</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Pharmacognosy, University of Science and Technology Meghalaya Technocity, Ri-Bhoi, Meghalaya 793101, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shrikant Deokar</LastName><ForeName>Savita</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>PES's Modern College of Pharmacy, Nigdi, Pune, Maharashtra 411044, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Behera</LastName><ForeName>Ashok</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Faculty of Pharmacy, DIT University, Dehradun, Uttarakhand 248009, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dhawal Bhandari</LastName><ForeName>Divya</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>University Institute of Pharmaceutical Sciences, Panjab University, Chandigarh 160014, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gaikwad</LastName><ForeName>Nikita</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Pharmaceutics, P.E.S. Modern College of Pharmacy, Nigdi, Pune 411044, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kalam Azad</LastName><ForeName>Abul</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Faculty of Pharmacy, MAHSA University, Bandar Saujana Putra, Selangor 42610, Malaysia. Electronic address: aphdukm@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ghosh</LastName><ForeName>Arabinda</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Computational Biology and Biotechnology, Mahapurusha Srimanta Sankaradeva Viswavidyalaya, Guwahati, Assam 781032, India. Electronic address: dra.ghosh@gauhat.ac.in.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Mitochondrion</MedlineTA><NlmUniqueID>100968751</NlmUniqueID><ISSNLinking>1567-7249</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010300" MajorTopicYN="Y">Parkinson Disease</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006816" MajorTopicYN="Y">Huntington Disease</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018384" MajorTopicYN="N">Oxidative Stress</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008928" MajorTopicYN="N">Mitochondria</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer's diseases</Keyword><Keyword MajorTopicYN="N">Amyotrophic Lateral Sclerosis</Keyword><Keyword MajorTopicYN="N">Huntington's diseases</Keyword><Keyword MajorTopicYN="N">Mitochondrial dysfunction</Keyword><Keyword MajorTopicYN="N">Parkinson's diseases</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>5</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>5</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>12</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>4</Day><Hour>1</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>3</Day><Hour>19</Hour><Minute>23</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37269968</ArticleId><ArticleId IdType="doi">10.1016/j.mito.2023.05.007</ArticleId><ArticleId IdType="pii">S1567-7249(23)00051-X</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>